Cargando…
Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats
The profile of sphingomyelin and its metabolites shows changes in the plasma, organs, and tissues of patients with cardiovascular, renal, and metabolic diseases. The objective of this study was to investigate the effect of empagliflozin on the levels of sphingomyelin and its metabolites, as well as...
Autores principales: | Pérez-Villavicencio, Roxana, Flores-Estrada, Javier, Franco, Martha, Escalante, Bruno, Pérez-Méndez, Oscar, Mercado, Adriana, Bautista-Pérez, Rocio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910883/ https://www.ncbi.nlm.nih.gov/pubmed/35270028 http://dx.doi.org/10.3390/ijms23052883 |
Ejemplares similares
-
Sphingolipid Catabolism and Glycerophospholipid Levels Are Altered in Erythrocytes and Plasma from Multiple Sclerosis Patients
por: Momchilova, Albena, et al.
Publicado: (2022) -
The Role of P2X7 Purinergic Receptors in the Renal Inflammation Associated with Angiotensin II-Induced Hypertension
por: Bautista-Pérez, Rocio, et al.
Publicado: (2020) -
Transcriptional suppression of sphingolipid catabolism controls pathogen resistance in C. elegans
por: Nasrallah, Mohamad A., et al.
Publicado: (2023) -
Metabolismo de los esfingolípidos y su relación con las enfermedades cardiovasculares, renales y metabólicas
por: Hernández-Bello, Fernando, et al.
Publicado: (2023) -
Spinach Methanolic Extract Attenuates the Retinal Degeneration in Diabetic Rats
por: Bautista-Pérez, Rocio, et al.
Publicado: (2021)